HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Notice of Intent Replacement Cell Separators. The project location is USA and the tender is closing on 05 Apr 2024. The tender notice number is 24-006121, while the TOT Ref Number is 99203420. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Notice of Intent Replacement Cell Separators

Deadline : 05 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99203420

Document Ref. No. : 24-006121

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : BETHESDA, MD 20892
Primary Point of Contact : Damien Goines
damien.goines@nih.gov
Phone Number 3018274879

USA
Email :damien.goines@nih.gov

Tender Details

Description

Notice of Intent Blood Services Section, TerumoBCT Spectra Optia Blood

Cell Separators Purchase



Product Service Code: 6515 - Medical and Surgical Instruments, Equipment, and Supplies NAICS Code: 339112 - (Not Small Business Size Standards- 1, 250 Average Number of Employees) Place of Performance: Bethesda, MD 20892 USA

POTS: 24-006121



Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.



The Department of Transfusion Medicine (DTM) serves as the clinical laboratory of the National Institutes of Health (NIH). Clinical Center. Provide high quality patient care and hospital services in support of NIH clinical research programs, to pursue research that contributes to our knowledge and practice of transfusion medicine and related technologies, and to provide advanced training in transfusion medicine. Together these programs promote the basic goals of the Clinical Center. The NIH and DHHS: that is, to enhance the health and well-being of Americans.



The purpose of this requirement is to acquire two new automated blood cells

Separators, 2 61000 Spectra Optia Apheresis System



The recommended service life for the Optia is 10 years. Our oldest Spectra Optias were purchased in 2013. There are certain components in the older instruments which have become obsolete and unavailable from service suppliers.



Terumo BCT, Colorado 80215-4440 is uniquely qualified to replace the existing Spectra Optia Apheresis System. Terumo BCT T is the sole source manufacture of the Spectra Optia and is the only known distributor of the compatible equipment. There are devices on the market that perform one or a mix of these collections, but the TerumoBCT Spectra Optia System is the only device on the market that does all these activities on the same platform. The recommended service life for the Optia is 10 years. Ext...
Active Contract Opportunity Notice ID 24-006121 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH - CC
General Information
Contract Opportunity Type: Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 22, 2024 07:22 am EDT
Original Date Offers Due: Apr 05, 2024 08:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Apr 20, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice